Tareq Juratli
Tareq Juratli
Assistant Professor of Neurosurgery, University Hospital Dresden/ Former postdoc. MGH
Verified email at uniklinikum-dresden.de
Cited by
Cited by
Current status of local therapy in malignant gliomas—a clinical review of three selected approaches
TA Juratli, G Schackert, D Krex
Pharmacology & therapeutics 139 (3), 341-358, 2013
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
TA Juratli, M Kirsch, K Robel, S Soucek, K Geiger, R von Kummer, ...
Journal of neuro-oncology 108 (3), 403-410, 2012
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
PN Harter, S Bernatz, A Scholz, PS Zeiner, J Zinke, M Kiyose, S Blasel, ...
Oncotarget 6 (38), 40836, 2015
Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study
TA Juratli, B Zang, RJ Litz, KH Sitoci, U Aschenbrenner, B Gottschlich, ...
Journal of neurotrauma 31 (17), 1521-1527, 2014
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas
TA Juratli, M Kirsch, K Geiger, B Klink, E Leipnitz, T Pinzer, S Soucek, ...
Journal of neuro-oncology 110 (3), 325-333, 2012
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
TA Juratli, C Thiede, MVA Koerner, SS Tummala, D Daubner, ...
Oncotarget 8 (65), 109228, 2017
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
TA Juratli, D McCabe, N Nayyar, EA Williams, IM Silverman, SS Tummala, ...
Acta neuropathologica 136 (5), 779-792, 2018
Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain
J Klein, S Sandi-Gahun, G Schackert, TA Juratli
Cephalalgia 36 (5), 445-453, 2016
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
TA Juratli, SS Tummala, A Riedl, D Daubner, S Hennig, T Penson, A Zolal, ...
Journal of neuro-oncology 141 (2), 327-335, 2019
Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
A Seidlitz, T Siepmann, S Löck, T Juratli, M Baumann, M Krause
Radiation Oncology 10 (1), 1-10, 2015
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
MR Strickland, CM Gill, N Nayyar, MR D'Andrea, C Thiede, TA Juratli, ...
Journal of neurosurgery 127 (2), 438-444, 2017
TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas: a pilot prospective study
TA Juratli, S Stasik, A Zolal, C Schuster, S Richter, D Daubner, MA Juratli, ...
Clinical Cancer Research 24 (21), 5282-5291, 2018
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
C Mirian, AK Duun-Henriksen, T Juratli, F Sahm, S Spiegl-Kreinecker, ...
Journal of Neurology, Neurosurgery & Psychiatry 91 (4), 378-387, 2020
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas
TA Juratli, M Peitzsch, K Geiger, G Schackert, G Eisenhofer, D Krex
Neuro-oncology 15 (6), 682-690, 2013
The prostate stem cell antigen represents a novel glioma-associated antigen
KD Geiger, S Hendruschk, EP Rieber, A Morgenroth, B Weigle, T Juratli, ...
Oncology reports 26 (1), 13-21, 2011
Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry
MA Juratli, YA Menyaev, M Sarimollaoglu, ER Siegel, DA Nedosekin, ...
PLoS One 11 (5), e0156269, 2016
Percutaneous pedicle screw and rod fixation with TLIF in a series of 14 patients with recurrent lumbar disc herniation
M Niesche, TA Juratli, KH Sitoci, J Neidel, D Daubner, G Schackert, ...
Clinical neurology and neurosurgery 124, 25-31, 2014
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
TA Juratli, PS Jones, N Wang, M Subramanian, SJB Aylwin, Y Odia, ...
Cancer 125 (17), 2910-2914, 2019
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas
S Fujio, TA Juratli, K Arita, H Hirano, Y Nagano, T Takajo, K Yoshimoto, ...
Neurosurgery 85 (2), 204-210, 2019
The system can't perform the operation now. Try again later.
Articles 1–20